South Bend, IN, United States of America

Jonathan C Bernhard

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Symic IP, LLC. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan C Bernhard. Retrieved from https://idiyas.com/inventor/jonathan-c-bernhard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan C. Bernhard

Introduction: Jonathan C. Bernhard, an accomplished inventor based in South Bend, Indiana, has made significant strides in the field of biotechnology. His pioneering work focuses on the development of hyaluronic acid-binding synthetic peptidoglycans, which has promising applications in various medical and industrial domains.

Latest Patents: Jonathan holds one notable patent titled "Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use." This invention pertains to the field of synthetic peptidoglycans, detailing innovative methods for their formation and practical uses. This patent reflects his commitment to advancing biotechnological solutions.

Career Highlights: Jonathan is currently employed at Symic IP, LLC, where he combines his expertise with a dedicated team to push boundary limits within the innovation landscape. His work exemplifies a rare blend of scientific knowledge and technical prowess.

Collaborations: Jonathan collaborates closely with notable professionals, including Alyssa Panitch and John Eric Paderi. Their combined expertise fosters a creative environment that enhances problem-solving and drives forward-thinking innovations in their projects.

Conclusion: Jonathan C. Bernhard’s contributions to the realm of synthetic peptidoglycans represent a crucial advancement that could reshape the industry. His ongoing work at Symic IP, LLC, alongside esteemed colleagues, continues to illuminate the path toward innovative solutions in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…